Cargando…
Metabolic lipid muscle disorders: biomarkers and treatment
Lipid storage myopathies (LSMs) are metabolic disorders of the utilization of fat in muscles due to several different defects. In this review, a molecular update of LSMs is presented and recent attempts of finding treatment options are discussed. The main topics discussed are: primary carnitine defi...
Autores principales: | Angelini, Corrado, Pennisi, Elena, Missaglia, Sara, Tavian, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477769/ https://www.ncbi.nlm.nih.gov/pubmed/31040882 http://dx.doi.org/10.1177/1756286419843359 |
Ejemplares similares
-
MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy
por: Pegoraro, Valentina, et al.
Publicado: (2019) -
Neutral lipid storage disease with myopathy: A 10-year follow-up case report
por: Missaglia, Sara, et al.
Publicado: (2022) -
Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
por: Missaglia, Sara, et al.
Publicado: (2018) -
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients
por: Noguera, Nelida Inés, et al.
Publicado: (2023) -
Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function
por: Missaglia, Sara, et al.
Publicado: (2019)